The RAPPORT clinical trial: interim safety analysis of combination SABR with adjuvant anti-PD1 immunotherapy in oligometastatic renal cell carcinoma
Shankar Siva, Mathias Bressel, Mark Shaw, Sarat Chander, Sherene Loi, David Pryor, Shahneen Sandhu, Jennifer Mooi, Dasantha Jayamanne, Thomas Eade, Nathan Lawrentschuk, Declan Murphy, Jeremy Lewin, Ben Tran, Farshad Foroudi (2018). The RAPPORT clinical trial: interim safety analysis of combination SABR with adjuvant anti-PD1 immunotherapy in oligometastatic renal cell carcinoma.
